Friday Apr 11
The Stalled State Of MannKind
MannKind stock peaked in the wee hours of pre-market trading the day following a near unanimous adcom victory, but might not equal that fondly remembered price for years to come.
Trending on the Topix Network
Friday Apr 11
FDA Recommendations, Study Publications, Recognitions, Agreements,...
Today, Analysts Review released its analysts' notes regarding MannKind Corp. , Acceleron Pharma, Inc. , Steris Corp. , Retrophin, Inc. , and NxStage Medical, Inc. .
Tue Apr 08, 2014
MannKind Receives New Coverage from Analysts at Brinson Patrick
Shares of MannKind opened at 6.32 on Tuesday. MannKind has a 52 week low of $3.72 and a 52 week high of $8.70.
Mon Apr 07, 2014
MannKind Corporation Drops As The FDA Delays Decision On Inhaled Insulin Treatment
MannKind Updates Status of New Drug Application for AFREZZA VALENCIA, Calif., Apr 07, 2014 -- MannKind Corporation MNKD -12.25% today announced that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act date for AFREZZAA by three months to July 15, 2014 in order to provide time for a full review of information ... (more)
Thu Apr 03, 2014
The Zacks Analyst Blog Highlights: Gilead, MannKind, Cubist, Regeneron and Medicines Co
Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
How MannKind Shows Depth Of The Diabetes Market
MannKind's surprise recommendation of approval for its diabetic inhaler by a Food and Drug Administration panel this week provides another platform to discuss this multibillion area of pharmaceuticals.
Pre-Market: US Economy Adds 191,000 Private Sector Jobs; Shares of...
Before the opening bell, Dow Jones futures rose 0.11% to 16,467. Futures on the S&P 500 were up 0.06% to 1,879.00.
Wed Apr 02, 2014
Shares Of MannKind, Intuitive Surgical Soar On FDA OKs
The Food and Drug Administration controls the food on your plate and the medication used to treat your ailments.
Mannkind's inhaled insulin clears big
Danbury-based MannKind's hopes for Afrezza, an inhaled diabetes drug, took a major step forward this week when an advisory panel recommended the Food and Drug Administration approve the treatment.
Mid-Afternoon Market Update: MannKind Hangs Onto its Gains as Yelp Shares Drop
Toward the end of trading Wednesday, the Dow traded up 0.18 percent to 16,562.46 while the NASDAQ surged 0.05 percent to 4,270.78.
Mid-Day Market Update: Apollo Drops After Q2 Results; MannKind Shares Spike Higher
Midway through trading Wednesday, the Dow traded up 0.11 percent to 16,551.46 while the NASDAQ surged 0.09 percent to 4,271.78.
MannKind PT Lowered to $5.00
Cowen and Company's price objective would suggest a potential upside of 24.38% from the company's current price.
MannKind Doubles on FDA News, Could Drive Short Covering in Biotech Sector
You will receive a download link right in your email inbox for each of the free reports that you choose.
Tue Apr 01, 2014
FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind...
MannKind Corporation today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration voted 13 to 1 to recommend that AFREZZA Inhalation Powder be granted marketing approval by the FDA to improve glycemic control in adults with type 1 diabetes and voted 14 to 0 to recommend that AFREZZA be ... (more)
Alcoa Inc. Plans to Trim 147,000 Metric Tons of Aluminum Smelting...
AA shares closed up 3.13% on Monday with nearly 40 million shares traded. The stock was one of the most active stocks on the NYSE and hit a new yearly high of $12.97 during intra-day trading.
Mon Mar 31, 2014
Mid-Afternoon Market Update: American Capital Rises as MannKind Shares Take a Hit
Toward the end of trading Monday, the Dow traded up 0.83 percent to 16,459.76 while the NASDAQ surged 1.12 percent to 4,202.81.
Free Falling MannKind Corporation (MNKD) Entices Options Bears
Food and Drug Administration concerns , the pharmaceutical stock is down another 16% this afternoon at $4.07, thanks to a bearish brokerage note from Piper Jaffray earlier.
Sun Mar 30, 2014
Yahoo Director John Hayes to Step Down; MannKind Corp.'s Afrezza...
YHOO shares modestly closed in the green this past Friday up almost 1%. The stock traded nearly 18.3 million shares and was one of the most active stocks on the NASDAQ.
Fri Mar 28, 2014
Option Clips: Ariad Pharmaceuticals, MannKind, and Kroger
StockTwits today are oncology concern Ariad Pharmaceuticals, Inc. and biopharmaceutical issue MannKind Corporation .
The Washington Post
MannKind's Inhaled Insulin Tied to Lung Function Concerns
MannKind Corp.'s inhaled diabetes drug, found to be effective against Type 2 diabetes, is linked to potential breathing problems that may limit its use in patients with lung diseases, U.S. regulators said.